Related Experiment Videos

Colloid versus crystalloid cardioplegia. A prospective, randomized clinical study

H Lindberg1, E Ovrum, E A Holen

  • 1Department of Cardiovascular Surgery, Rikshospitalet, National Hospital of Norway, Oslo.

Insights

Adding dextran 40 (Rheomacrodex) to cardioplegic solution improved microcirculation and chest X-ray recovery after coronary artery bypass grafting. Clinical outcomes remained similar between groups.

Area of Science:

  • Cardiovascular Surgery
  • Cardiothoracic Anesthesia
  • Biomaterials Science

Background:

  • Coronary artery bypass grafting (CABG) requires myocardial protection during surgery.
  • Cardioplegic solutions are crucial for preserving heart function during cardiac arrest.
  • Optimizing cardioplegic solution composition may enhance postoperative recovery.

Purpose of the Study:

  • To investigate the impact of adding dextran 40 (Rheomacrodex) to a crystalloid cardioplegic solution (St Thomas II) in CABG patients.
  • To assess the effects on microcirculation and early postoperative recovery.

Main Methods:

  • A randomized controlled trial involving 55 male patients undergoing CABG.
  • Group I (n=27) received St Thomas II cardioplegic solution with 35g dextran 40.
  • Group II (n=28) received standard crystalloid St Thomas II cardioplegic solution.

Main Results:

  • Patients receiving dextran 40 showed transiently elevated pulmonary vascular resistance index post-extracorporeal circulation.
  • Oxygen consumption and arteriovenous oxygen content difference were higher 2 hours postoperatively in the dextran 40 group, indicating improved microcirculation.
  • Faster normalization of chest X-rays was observed in the dextran 40 group.

Conclusions:

  • Addition of dextran 40 to cardioplegic solution may enhance myocardial microcirculation and accelerate pulmonary recovery after CABG.
  • While microcirculatory benefits were suggested, overall clinical outcomes were comparable between groups.

Related Concept Videos